<DOC>
	<DOCNO>NCT01189344</DOCNO>
	<brief_summary>Intestinal absorption levothyroxine ( LT4 ) tablets depend dissolution gastric acid secretion , reduce bariatric intervention . Impaired LT4 absorption due low gastric dissolution report patient atrophic chronic gastritis . The objective study evaluate absorption LT4 tablet morbidly obese patient Roux-en-Y bariatric surgery .</brief_summary>
	<brief_title>Levothyroxine ( L-T4 ) Absorption After Bariatric Surgery</brief_title>
	<detailed_description>LEVOTHYROXINE ABSORPTION IN MORBIDLY OBESE PATIENTS BEFORE AND AFTER ROUX-EN-Y BARIATRIC SURGERY INTRODUCTION Levothyroxine sodium ( LT4 ) effective drug prescribe replacement therapy patient hypothyroidism , controversial suppressive therapy nodular thyroid disease surgical removal thyroid cancer . Incidence rate differentiate thyroid cancer size increase men woman , rate autoimmune thyroiditis disease . It estimate 3.7 % United States population hypothyroidism , indicate million people continuous use LT4 . Absorption LT4 formulation approximate 80 % oral dose . It reduce LT4 ingest concomitantly several drug include aluminum hydroxide , cholestyramine , sucralfate , ferrous sulphate , calcium carbonate , sodium polystyrene sulfonate , well coffee fiber supplement . Intestinal absorption LT4 depend primarily dissolution gastric acid secretion . Therefore , may affect H. pylori infection autoimmune gastritis . There substantial interindividual variation LT4 requirement dependent patient age , gender body size , lean body mass major determinant dose correction LT4 . Morbidly obese patient apparently impaired LT4 absorption . The prevalence obesity increase epidemic proportion . Effective treatment may achieve bariatric surgery , procedure associate several morbidity , gastrointestinal nutritional complication . It plausible hypothesize since bariatric intervention ( Roux-en-Y ) reduce gastric hydrochloric acid secretion , may impair LT4 absorption . OBJECTIVE The aim study evaluate absorption LT4 tablet morbidly obese patient bariatric surgery order determine need adjustment LT4 dose . MATERIAL AND METHODS Patients Patients recruit Gastric Surgery Division Hospital das Clínicas . Thirty morbidly obese patient divide two group . The NS group include 15 patient bariatric surgery plan . Body mass index ( BMI ) group patient ≥40 Kg/m2 . The S group include 15 patient undergone Roux-en-Y bariatric surgery 2 3 month inclusion study . Clinical data medication information collect recruitment . Exclusion criterion include previous diagnosis thyroid cancer , diabetes mellitus use insulin , chronic atrophic gastritis , use medication associate impaired LT4 absorption . All patient sign informed consent . The study approve Ethical Committee Hospital das Clínicas , University São Paulo Medical School ( CAPPesq N0 1039/07 ) . Methods Absorption LT4 measure use previously describe nonisotopic method . After overnight fast , forearm intravenous catheter insert two blood sample collect 30-minute interval administration 600 µg oral LT4 . Blood sample collect 30 , 60 , 120 , 180 , 240 , 300 , 1440 minute ( 24 hour ) administration LT4 . Patients fast five hour receive drug . They instruct light meal even return next morning fast state collect 24 hour sample . Serum free T4 ( FT4 ) , total T4 ( TT4 ) serum TSH determine sample electrochemiluminescence immunoassay ( Roche Corporation , Indianapolis , IN , USA ) . The concentration hormone baseline calculate mean two sample collect LT4 dose . To correct endogenous hormone synthesis , incremental rise hormone concentration ( deltaTT4 , deltaFT4 , deltaTSH ) calculate subtract basal value subsequent time interval sample . To evaluate LT4 absorption , area curve deltaTT4 deltaFT4 baseline 240 minute 300 minute ( AUC240 , AUC300 ) well peak deltaTT4 deltaFT4 concentration determine . Serum leptin measure Human Leptin Elisa Kit ( Millipore , Billerica , MA ) patient , weight loss follow surgery . Chronic autoimmune gastritis rule absence clinical sign negative antiparietal autoantibody . Statistical analysis Results express mean±standard deviation ( SD ) . Analysis variance Tukey Multiple Comparison test , Student 's test Spearman correlation analysis perform compare data . All test perform significance level 5 % .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>morbidly obese individual ( body mass index ( BMI ) ≥40 Kg/m2 ) individual bariatric surgery indicate patient undergone RouxenY bariatric surgery 2 3 month inclusion study previous diagnosis thyroid cancer diabetes mellitus use insulin chronic atrophic gastritis use medication associate impaired LT4 absorption .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Obesity</keyword>
	<keyword>LT4</keyword>
	<keyword>Absorption</keyword>
	<keyword>Thyroid function</keyword>
</DOC>